4Q6R | Crystal structure of human sphingosine-1-phosphate lyase in complex with inhibitor 6-[(2R)-4-(4-benzyl-7-chlorophthalazin-1-yl)-2-methylpiperazin-1-yl]pyridine-3-carbonitrile | date | |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Srinivas, H. | ||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.40 | ||||||||||||
ligand | 30J, GOL, LLP, PO4, SIN | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Orally Active 7-Substituted (4-Benzyl-phthalazin-1-yl)-2-methyl-piperazin-1-yl]-nicotinonitriles as Active-site Inhibitors of Sphingosine-1-Phosphate Lyase for the Treatment of Multiple Sclerosis., Weiler S, Braendlin N, Beerli C, Bergsdorf C, Schubart A, Srinivas H, Oberhauser B, Billich A, J Med Chem. 2014 May 8. PMID:24809814 |
Data retrieval |
View 4Q6R in 3D |
Visual 3D analysis of 4Q6R |
Structure-derived information |
Sequence-derived information |
Other resources with information on 4Q6R |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |